HistoCyte – Lung Cancer controls

Gaining over 15,000 cases this 2024 and leading with the lowest survival rate for cancer types, lung cancer has been in the forefront of cancer cases in Australia. Biomarkers such ALK, ROS1, PD-L1, and BRAF are used in IHC and molecular laboratory techniques to identify specific types of lung cancer and guide targeted therapy.

Read more

Cell Marque ARID1A (EP303)

ARID1A is expressed in most normal tissue, and mutations occur in tumours resulting in a loss of expression. ARID1A mutations have been particularly relevant in GI and gynaecological malignancies.

Read more
Top
Abacus dx